Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| WILLIS TOWERS WATSON PLCWTW · Entity 3139 | Pres.-Health, Wealth & Career | October 09, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
WILLIS TOWERS WATSON PLC
Report date October 09, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Share UnitSEC Table II · derivative / convertible security | Direct | 24,632.1102 |
Reported balance
After 2026-10-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-10-09 · Grant · Acquired 63.4612 · Balance 24,632.1102 F1: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan. |
| Restricted Share UnitSEC Table II · derivative / convertible security | Direct | 5,639.6802 |
Reported balance
After 2026-10-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-09 · Grant · Acquired 13.3413 · Balance 5,639.6802 F3: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date.
F2: Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan.
F3: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.
F4: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2022 Filed Sep 6, 2022 20:00 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | SaleOrdinary Shares, nominal value $0.000304635 per share | 1,400 | $210.00 | $294,002.94 |
DisclosureSEC source: 0001127602-22-022093 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,155 F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. F2 · price: This transaction was executed in multiple trades at prices ranging from $210.00 to $210.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 20:01 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | SaleOrdinary Shares, nominal value $0.000304635 per share | 1,400 | $210.01 | $294,014.00 |
DisclosureSEC source: 0001127602-22-020557 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,555 F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. F2 · price: This transaction was executed in multiple trades at prices ranging from $210.00 to $210.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 1,202.036 restricted share units subject to the satisfaction of vesting requirements. Read SEC document |
| August 04, 2022 Filed Aug 8, 2022 20:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 126.0011 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020679 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,077.3482 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 126.0011 shares Expires not disclosed F1 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F2 · shares: Includes restricted share units acquired pursuant to the Company's contribution under the terms of the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account. F1 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F1 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 20:05 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | OtherDividend Equivalent Rights · Derivative | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019657 · form4.xml · derivative · entry 5 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 34 shares Expires not disclosed F2 · derivative.exercise_price: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F2 · derivative.exercise_date: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F2 · derivative.expiration_date: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 20:05 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | Tax withholdingOrdinary Shares, nominal value $0.000304635 per share | 1,483 | $198.47 | $294,331.01 |
DisclosureSEC source: 0001127602-22-019657 · form4.xml · nonDerivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,955 F1 · shares: Withholding of shares by Issuer incident to the vesting and settlement of an aggregate of 4,445 performance-based restricted share units on July 20, 2022. Read SEC document |
| July 20, 2022 Filed Jul 22, 2022 20:05 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | OtherOrdinary Shares, nominal value $0.000304635 per share | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019657 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,438 Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantDividend Equivalent Rights · Derivative | 5.036 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019485 · form4.xml · derivative · entry 5 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5.036 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 5.036 shares Expires not disclosed F7 · derivative.exercise_price: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F7 · shares: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F7 · derivative.exercise_date: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F7 · derivative.expiration_date: The dividend equivalent rights accrued on a time-based restricted share unit award and will vest based on the same vesting schedule applicable to the underlying restricted share unit award. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantDividend Equivalent Rights · Derivative | 18.623 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019485 · form4.xml · derivative · entry 4 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34.07 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 18.623 shares Expires not disclosed F6 · derivative.exercise_price: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F6 · shares: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F6 · derivative.exercise_date: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F6 · derivative.expiration_date: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 16.5549 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019485 · form4.xml · derivative · entry 3 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,951.3471 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 16.5549 shares Expires not disclosed F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units. F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 8.4924 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019485 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,514.5338 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 8.4924 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Represents dividends acquired pursuant to the Company's matching contribution on the participant's deferral pursuant to the terms of the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees and credited to the participant's account in the form of restricted share units. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 81.372 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019485 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,506.0414 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 81.372 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Represents dividends acquired under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees pursuant to the participant's deferral election and automatic deferral of earned awards under the Company's Long-Term Incentive Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 20:02 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 24.1168 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-019261 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,424.6695 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 24.1168 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| July 11, 2022 Filed Jul 13, 2022 20:02 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 41.3431 | $199.24 | $8,237.20 |
DisclosureSEC source: 0001127602-22-019261 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,400.5527 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 41.3431 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 20:02 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | SaleOrdinary Shares, nominal value $0.000304635 per share | 1,400 | $210.67 | $294,938.00 |
DisclosureSEC source: 0001127602-22-016357 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,404 F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. F2 · balance_after: Includes 5,608 restricted share units subject to the satisfaction of vesting requirements. Read SEC document |
| May 06, 2022 Filed May 10, 2022 20:04 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 526.1757 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013953 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,934.7924 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 526.1757 shares Expires not disclosed F1 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F2 · shares: Includes restricted share units acquired pursuant to the Company's contribution under the terms of the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account. F1 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F1 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| May 02, 2022 Filed May 3, 2022 20:00 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | SaleOrdinary Shares, nominal value $0.000304635 per share | 400 | $214.85 | $85,940.00 |
DisclosureSEC source: 0001127602-22-013008 · form4.xml · nonDerivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,804 F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. F2 · balance_after: Includes 1,197 time-based restricted share units subject to the satisfaction of vesting requirements. Read SEC document |
| May 02, 2022 Filed May 3, 2022 20:00 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | SaleOrdinary Shares, nominal value $0.000304635 per share | 1,000 | $213.82 | $213,820.00 |
DisclosureSEC source: 0001127602-22-013008 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,204 F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 20:56 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 105.0153 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012587 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,359.2096 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 105.0153 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 20:56 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 180.0262 | $241.06 | $43,397.12 |
DisclosureSEC source: 0001127602-22-012587 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,254.1943 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 180.0262 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 21:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 11.9433 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012163 · form4.xml · derivative · entry 3 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,408.6166 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 11.9433 shares Expires not disclosed F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units. F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 21:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 6.7045 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012163 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,074.1681 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 6.7045 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Represents dividends acquired pursuant to the Company's matching contribution on the participant's deferral pursuant to the terms of the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees and credited to the participant's account in the form of restricted share units. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| April 18, 2022 Filed Apr 19, 2022 21:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 67.1357 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012163 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,067.4636 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 67.1357 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Represents dividends acquired under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees pursuant to the participant's deferral election and automatic deferral of earned awards under the Company's Long-Term Incentive Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| April 15, 2022 Filed Apr 19, 2022 21:07 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantDividend Equivalent Rights · Derivative | 15.447 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012163 · form4.xml · derivative · entry 4 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15.447 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 15.447 shares Expires not disclosed F6 · derivative.exercise_price: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F6 · derivative.exercise_date: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. F6 · derivative.expiration_date: The dividend equivalent rights accrued on a number of performance-based restricted share units previously earned under the reporting person's performance-based restricted share unit award and credited in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Each dividend equivalent right is the economic equivalent of one WTW Ordinary Share. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:09 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | GrantOrdinary Shares, nominal value $0.000304635 per share | 1,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011528 · form4.xml · nonDerivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,204 F2 · shares: Comprised of 1,197 time-based restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest ratably over a three-year period as of the first, second and third anniversaries of the grant date. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 20:09 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | SaleOrdinary Shares, nominal value $0.000304635 per share | 1,400 | $236.88 | $331,632.00 |
DisclosureSEC source: 0001127602-22-011528 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,007 F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:00 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | SaleOrdinary Shares, nominal value $0.000304635 per share | 1,400 | $222.30 | $311,220.00 |
DisclosureSEC source: 0001127602-22-007634 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,407 F1 · shares: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during an open trading window in a prior quarter. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:34 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | Tax withholdingOrdinary Shares, nominal value $0.000304635 per share | 114 | $225.61 | $25,719.54 |
DisclosureSEC source: 0001127602-22-006619 · form4.xml · nonDerivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,807 F2 · shares: Represents the number of ordinary shares of the Issuer withheld by the Issuer from the ordinary shares that are eventually eligible to be issued upon the vesting date of July 20, 2022 to satisfy the reporting person's FICA tax withholding obligations relating to the number of performance-based restricted share units that were deemed to be earned as of the performance goal attainment level certification date and to be eligible to vest on the vesting date and based on the reporting person's retirement-vesting eligibility status as of the performance goal attainment level certification date. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:34 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantOrdinary Shares, nominal value $0.000304635 per share | 4,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006619 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,921 F1 · shares: Represents the number of performance-based restricted share units earned upon the certification of the achievement of certain pre-established performance goals based on three-year annualized total shareholder return during the three-year performance period that ended on December 31, 2021, each of which earned unit represents the right to receive one ordinary share of the Issuer upon the satisfaction of the service-based vesting requirement on July 20, 2022, subject to the terms of the award agreement. This number also includes the number of ordinary shares of the Issuer that are issuable pursuant to the dividend equivalent right under the terms of the award agreement providing for the accrual of dividends in the form of additional restricted share units that vest and are payable at the same time as the underlying performance-based restricted share units. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 21:00 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | SaleOrdinary Shares, nominal value $0.000304635 per share | 2,400 | $220.99 | $530,375.28 |
DisclosureSEC source: 0001127602-22-005280 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,396 F1 · kind: The sales reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $220.48 to $221.3883. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 21:05 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 112.8928 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-004545 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,396.6734 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 112.8928 shares Expires not disclosed F1 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F2 · shares: Includes restricted share units acquired pursuant to the Company's contribution under the terms of the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account. F1 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F1 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 21:03 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 11.5241 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001694 · form4.xml · derivative · entry 3 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,283.7806 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 11.5241 shares Expires not disclosed F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units. F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 21:03 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 6.6054 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001694 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000.3279 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 6.6054 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Represents dividends acquired pursuant to the Company's matching contribution on the participant's deferral pursuant to the terms of the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees and credited to the participant's account in the form of restricted share units. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 21:03 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 66.859 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001694 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,993.7225 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 66.859 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Represents dividends acquired under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees pursuant to the participant's deferral election and automatic deferral of earned awards under the Company's Long-Term Incentive Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 21:00 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 24.5514 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001379 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,926.8634 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 24.5514 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 21:00 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 42.0879 | $232.62 | $9,790.49 |
DisclosureSEC source: 0001127602-22-001379 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,902.312 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 42.0879 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:01 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | Exercise / conversionStock Option (right to buy) · Derivative | 42,010 | $0.00 Strike: $110.58 | $0.00 |
DisclosureSEC source: 0001127602-21-029417 · form4.xml · derivative · entry 6 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 42,010 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares underlying the option vested and were exercisable on July 1, 2018. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:01 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | Disposition to issuerOrdinary Shares, nominal value $0.000304635 per share | 26,175 | $229.28 | $6,001,341.18 |
DisclosureSEC source: 0001127602-21-029417 · form4.xml · nonDerivative · entry 3 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,796 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:01 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | Disposition to issuerOrdinary Shares, nominal value $0.000304635 per share | 15,835 | $230.18 | $3,644,938.30 |
DisclosureSEC source: 0001127602-21-029417 · form4.xml · nonDerivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,971 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:01 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | Exercise / conversionOrdinary Shares, nominal value $0.000304635 per share | 42,010 | $110.58 | $4,645,465.80 |
DisclosureSEC source: 0001127602-21-029417 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 21:03 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 110.2688 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-028567 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,272.2566 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 110.2688 shares Expires not disclosed F1 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F2 · shares: Includes restricted share units acquired pursuant to the Company's contribution under the terms of the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account. F1 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F1 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:03 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 10.2119 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027316 · form4.xml · derivative · entry 3 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,161.9878 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 10.2119 shares Expires not disclosed F4 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units. F4 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F4 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:03 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 5.9815 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027316 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,860.2242 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 5.9815 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Represents dividends acquired pursuant to the Company's matching contribution on the participant's deferral pursuant to the terms of the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees and credited to the participant's account in the form of restricted share units. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 20:03 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 61.1821 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027316 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,854.2427 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 61.1821 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Represents dividends acquired under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees pursuant to the participant's deferral election and automatic deferral of earned awards under the Company's Long-Term Incentive Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 20:03 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 23.5297 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-027017 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,793.0606 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 23.5297 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 20:03 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 40.3364 | $242.66 | $9,788.03 |
DisclosureSEC source: 0001127602-21-027017 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Health, Wealth &Career 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,769.5309 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 40.3364 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:00 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 115.3148 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023571 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Human Capital&Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,151.7759 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 115.3148 shares Expires not disclosed F1 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F2 · shares: Includes restricted share units acquired pursuant to the Company's contribution under the terms of the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account. F1 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F1 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 20:08 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | Tax withholdingOrdinary Shares, nominal value $0.000304635 per share | 3,388 | $216.09 | $732,112.92 |
DisclosureSEC source: 0001127602-21-022375 · form4.xml · nonDerivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Human Capital&Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,796.068 F1 · shares: Withholding of shares by Issuer incident to the vesting and settlement of an aggregate of 8,205 performance-based restricted share units on July 20, 2021. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 20:05 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 25.0614 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-021866 · form4.xml · derivative · entry 2 Gebauer Julie Jarecke · CIK 0001477865 · Head of Human Capital&Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,729.1946 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 25.0614 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F3 · shares: Includes restricted share units acquired pursuant to the Company's matching contribution on the participant's deferral election pursuant to the terms of the Plan and credited to the participant's account in the form of restricted share units under the Plan. F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 20:05 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 42.9623 | $228.21 | $9,804.43 |
DisclosureSEC source: 0001127602-21-021866 · form4.xml · derivative · entry 1 Gebauer Julie Jarecke · CIK 0001477865 · Head of Human Capital&Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,704.1332 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 42.9623 shares Expires not disclosed F1 · derivative.exercise_price: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F2 · shares: Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"). F1 · derivative.exercise_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. F1 · derivative.expiration_date: Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:12 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantRestricted Share Unit · Derivative | 8.4113 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020173 · form4.xml · derivative · entry 6 Gebauer Julie Jarecke · CIK 0001477865 · Head of Human Capital&Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,036.4611 Underlying: Ordinary Shares, nominal value $0.000304635 per share · 8.4113 shares Expires not disclosed F5 · derivative.exercise_price: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F6 · shares: Represents dividends acquired pursuant to the Company's contribution under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees and credited to the participant's account in the form of restricted share units. F5 · derivative.exercise_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. F5 · derivative.expiration_date: Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.